Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIPEL.L Regulatory News (IPEL)

  • There is currently no data for IPEL

Share Purchase Plan

8 Jul 2022 13:00

RNS Number : 8816R
Impellam Group plc
08 July 2022
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

FOR IMMEDIATE RELEASE

8th July 2022

Impellam Group plc

("Impellam" or the "Company")

Share Purchase Plan

 

The Company announces the continuation of its trading plan (the "Share Purchase Plan") to buy back shares for cancellation. The continuation of the Share Purchase Plan will commence with immediate effect and will, unless terminated at an earlier date, expire on the date of the Company's next Annual General Meeting, when the Company will reconfirm its intentions.

Under the Share Purchase Plan, the Company will instruct its broker, Canaccord Genuity Limited, to acquire ordinary shares of 1 pence each in the Company ("Ordinary Shares"). Purchases of Ordinary Shares under the Share Purchase Plan will be limited to £0.5 million of Ordinary Shares (by market value) per calendar month up to the date of the Company's next Annual General Meeting, currently due to be held on 28 June 2023.

The maximum price paid for such Ordinary Shares shall be an amount equal to the higher of (i) 10% above the average of the middle market quotations for the Ordinary Shares as derived from the London Stock Exchange's Daily Official List for the five business days prior to making any purchase; and (ii) the higher of the price of the last independent trade of and the highest current independent bid for an Ordinary Share on the London Stock Exchange's AIM market. 

Notwithstanding the average daily volume restrictions set out in Article 3(3) (b) of the Commission Delegated Regulation (EU) 2016/1052, the Company may make purchases in excess of these volume restrictions, subject to prevailing market conditions and liquidity.

 

Enquiries:

Impellam Group plc

Julia Robertson, Chief Executive Officer

 

01582 692 658

Canaccord Genuity Ltd (Nomad and Sole Broker)

Andrew Potts

Bobbie Hilliam

Georgina McCooke

 

020 7523 8150

 

 

Rule 26.1 disclosure

In accordance with Rule 26.1 of the Code, a copy of this announcement will be available on the investor section of the Company's website at https://investors.impellam.com/ by no later than 12 noon (London time) on the business day immediately following the date of this announcement. The content of the website referred to in this announcement is not incorporated into and does not form part of this announcement.

 

Note to Editors:

Our Managed Services businesses are enabled by talent-focused Specialist Staffing brands with deep heritages, vertical sector expertise and loyal candidate networks. Clients across the world trust us to deliver Managed Services and Specialist Staffing in the UK, North America, Asia Pacific and Europe.

 

Working with them are 3,000 Impellam people, bringing a wealth of expertise through our 13 market-leading brands across 70 locations. Every year, we connect carefully chosen candidates with good work at all levels. They include technology and digital specialists, scientists, clinical experts, engineers, nurses, doctors, lawyers, teachers, receptionists, drivers, chefs, administrators, warehouse and call centre operatives.

 

Underpinning everything we do is our Virtuoso strategy which recognises it is our people who make the difference. Virtuosos make and deliver on promises, and grow with their customers through sector, service or international expansion which ensures there is never a need for a customer or candidate to leave Impellam. Impellam is the largest Global Talent Acquisition and Managed Workforce Solutions provider in the UK, and 8th1 in the world.

 

For more information about Impellam Group please visit: www.impellam.com

 

1 By SUM (confirmed by Staffing Industry Analysts). Spend Under Management (SUM) is the total amount of client expenditure which our Managed Services brands manage on behalf of their clients. This equates to revenue earned where Impellam acts as principal plus gross billings to customers where Impellam acts as agent (2020 published numbers). Management use this measure as it reflects the total value of the client spend to the Group and not just the revenue generated

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSDZGGNMRGGZZM
Date   Source Headline
22nd Nov 202311:40 amRNSForm 8.5 (EPT/RI)
22nd Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
21st Nov 20232:06 pmRNSForm 8.3 - Impellam Group Plc
21st Nov 202310:46 amRNSForm 8.5 (EPT/RI)
21st Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
16th Nov 202311:46 amRNSForm 8.3 - Impellam Group PLC
16th Nov 202311:24 amRNSForm 8.5 (EPT/RI)
16th Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
15th Nov 20231:33 pmRNSForm 8.3 - Impellam Group Plc
15th Nov 20239:29 amRNSForm 8.5 (EPT/RI)
15th Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
14th Nov 202312:36 pmRNSForm 8.3 - Impellam Group Plc
14th Nov 202310:34 amRNSForm 8.5 (EPT/RI)
14th Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
13th Nov 202311:51 amRNSForm 8.3 - Impellam Group Plc
13th Nov 202311:39 amRNSForm 8.5 (EPT/RI)
13th Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
10th Nov 202312:16 pmRNSForm 8.3 - Impellam Group Plc
10th Nov 202310:37 amRNSForm 8.5 (EPT/RI)
10th Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
9th Nov 202311:45 amRNSForm 8.3 - Impellam Group PLC
8th Nov 20235:46 pmRNSPUSU Extension and Interim Dividend
8th Nov 20234:07 pmRNSExtension of PUSU Deadline
8th Nov 20232:04 pmRNSForm 8.3 - Impellam Group PLC
7th Nov 202312:29 pmRNSForm 8.3 - Impellam Group PLC
7th Nov 202311:02 amRNSForm 8.5 (EPT/RI)
7th Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
6th Nov 202310:45 amRNSForm 8.3 - Impellam Group PLC
3rd Nov 202311:18 amRNSForm 8.3 - Impellam Group PLC
3rd Nov 20239:22 amRNSForm 8.5 (EPT/RI)
3rd Nov 20237:05 amRNSTransaction in Own Shares & Rule 2.9 Announcement
2nd Nov 202312:09 pmRNSForm 8.3 - Impellam Group PLC
2nd Nov 20239:57 amRNSForm 8.5 (EPT/RI)
2nd Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
1st Nov 20232:21 pmRNSForm 8.3 - Impellam Group PLC
1st Nov 202310:30 amRNSForm 8.5 (EPT/RI)
1st Nov 20238:30 amRNSTransaction in Own Shares & Rule 2.9 Announcement
1st Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
31st Oct 202311:28 amRNSForm 8.3 - Impellam Group PLC
30th Oct 202312:35 pmRNSForm 8.3 - Impellam Group PLC
26th Oct 202310:45 amRNSForm 8.5 (EPT/RI)
26th Oct 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
25th Oct 20233:41 pmRNSExtension of PUSU Deadline
25th Oct 202311:47 amRNSForm 8.5 (EPT/RI)
25th Oct 202311:17 amRNSForm 8.3 - Impellam Group plc
25th Oct 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
24th Oct 202311:07 amRNSForm 8.5 (EPT/RI)
24th Oct 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
18th Oct 202311:13 amRNSForm 8.5 (EPT/RI)
17th Oct 202311:38 amRNSForm 8.3 - Impellam Group PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.